Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen.
Saved in:
| Title: | Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen. |
|---|---|
| Authors: | Wan L; Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA., Xie B; Immunology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA., Shuda M; Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA., O'Malley ME; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15232, USA., Camacho CJ; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15232, USA., Delgoffe GM; Immunology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA., Chang Y; Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA. Electronic address: yc70@pitt.edu., Moore PS; Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA. Electronic address: psm9@pitt.edu. |
| Source: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
